Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

283.28
+2.160.77%
Volume:160.07K
Turnover:45.16M
Market Cap:500.66B
PE:80.03
High:283.32
Open:282.42
Low:280.50
Close:281.12
52wk High:283.32
52wk Low:190.75
Shares:1.77B
Float Shares:1.76B
Volume Ratio:1.72
T/O Rate:0.01%
Dividend:6.83
Dividend Rate:2.41%
EPS(TTM):3.54
EPS(LYR):2.36
ROE:6225.00%
ROA:10.51%
PB:-84.36
PE(LYR):120.03

Loading ...

CG Oncology Names Isabel Kalofonos Chief Commercial Officer

Reuters
·
1 hour ago

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
17 hours ago

Bausch + Lomb CEO Saunders Departs, Chairman Appio Named Interim Chief

Reuters
·
Yesterday

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Glaukos (GKOS)

TIPRANKS
·
Yesterday

Regenxbio to Host Investor Event on Sura-Vec Wet AMD Program Ahead of Pivotal Data Readout

Reuters
·
Yesterday

AbbVie Says Phase 3 Affirm Study Shows Subcutaneous Skyrizi Beats Placebo on Crohn’s Remission, Endoscopic Response at Week 12

Reuters
·
Yesterday

AbbVie Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Oct 10

U.S. Stocks on the MOVE -VF Corp, Biogen, AbbVie

Reuters
·
Oct 10

UBS Lifts AbbVie Target as Focus Expands Beyond Immunology Drugs

Reuters
·
Oct 09

Pharma Stocks Jump With Novavax up 12%, Moderna up 6%

Tiger Newspress
·
Oct 09

Abbvie Inc. : UBS Raises Target Price to $275 from $260

THOMSON REUTERS
·
Oct 09

AbbVie price target raised to $275 from $260 at UBS

TIPRANKS
·
Oct 09

BofA Securities Adjusts AbbVie Price Target to $305 From $289

MT Newswires Live
·
Oct 09

AbbVie price target raised to $305 from $289 at BofA

TIPRANKS
·
Oct 09

AbbVie is Maintained at Overweight by JP Morgan

Dow Jones
·
Oct 09

AbbVie Targets Jawline and Neck Aesthetics With New Botox and Juvéderm Study

TIPRANKS
·
Oct 09

AbbVie (ABBV) Lands Two FDA Breakthrough Tags For Temab A In Cancer

Simply Wall St.
·
Oct 08

Piper Sandler Sticks to Their Buy Rating for AbbVie (ABBV)

TIPRANKS
·
Oct 08

Movement Alert|AbbVie Rises 3.06% in Regular Trading, Boosted by FDA Breakthrough Therapy Designations for Cancer Drug

Market Focus
·
Oct 08

Pharma Stocks Rally With Amgen, Gilead Sciences up 3%

Tiger Newspress
·
Oct 07